EverSource Wealth Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.5K | Buy |
2,461
+179
| +8% | +$6.87K | ﹤0.01% | 1230 |
|
|
2025
Q1 | $88.4K | Sell |
2,282
-1,907
| -46% | -$73.9K | ﹤0.01% | 960 |
|
|
2024
Q4 | $142K | Buy |
4,189
+1,902
| +83% | +$64.3K | 0.01% | 797 |
|
|
2024
Q3 | $93.5K | Sell |
2,287
-1,255
| -35% | -$51.3K | 0.01% | 812 |
|
|
2024
Q2 | $137K | Buy |
3,542
+303
| +9% | +$11.7K | 0.01% | 688 |
|
|
2024
Q1 | $134K | Buy |
3,239
+558
| +21% | +$23.1K | 0.01% | 612 |
|
|
2023
Q4 | $99.4K | Sell |
2,681
-1,546
| -37% | -$57.3K | 0.01% | 640 |
|
|
2023
Q3 | $153K | Buy |
4,227
+843
| +25% | +$30.6K | 0.02% | 462 |
|
|
2023
Q2 | $121K | Buy |
3,384
+441
| +15% | +$15.7K | 0.01% | 519 |
|
|
2023
Q1 | $105K | Buy |
2,943
+416
| +16% | +$14.8K | 0.01% | 532 |
|
|
2022
Q4 | $88.8K | Sell |
2,527
-111
| -4% | -$3.9K | 0.01% | 545 |
|
|
2022
Q3 | $78K | Buy |
2,638
+564
| +27% | +$16.7K | 0.02% | 507 |
|
|
2022
Q2 | $113K | Buy |
2,074
+202
| +11% | +$11K | 0.03% | 345 |
|
|
2022
Q1 | $102K | Sell |
1,872
-32
| -2% | -$1.74K | 0.03% | 334 |
|
|
2021
Q4 | $105K | Buy |
+1,904
| New | +$105K | 0.03% | 303 |
|